XML 34 R20.htm IDEA: XBRL DOCUMENT v3.21.2
Income Taxes
9 Months Ended 12 Months Ended
Sep. 30, 2021
Dec. 31, 2020
Income Tax Disclosure [Abstract]    
Income Taxes
Note 8 – Income taxes
A valuation allowance has been established against the Company’s net U.S. federal and state deferred tax assets, including net operating loss (“NOL”) carryforwards. As a result, the Company’s income tax position is primarily related to foreign tax activity and U.S. deferred taxes for tax deductible goodwill and other indefinite-lived liabilities. During the three months ended September 30, 2021 and 2020, the Company recorded an income tax benefit of $1.0 million and a provision of $0.4 million, respectively, resulting in an effective tax rate of 3.3% and (3.3)%, respectively. During the nine months ended September 30, 2021 and 2020, the Company recorded an income tax benefit of $0.1 million and a provision of $1.0 million, respectively, resulting in an effective tax rate of 0.2% and (2.6)%, respectively. These effective tax rates differ from the U.S. federal statutory rate primarily due to the effects of foreign tax rate differences, state taxes and the valuation allowance against our domestic deferred tax assets.
Note 13 – Income taxes
The components of income tax expense for the years ended December 31, 2020 and 2019 are presented below (in thousands):
 
    
Year Ended

December 31,
2020
    
Year Ended

December 31,
2019
 
Current
                 
Federal
   $ (712    $ (37
State
     73        61  
Foreign
     729        447  
Deferred
                 
Federal
     334        332  
State
     806        705  
Foreign
     (294      (789
    
 
 
    
 
 
 
Total income tax provision
   $ 936      $ 719  
    
 
 
    
 
 
 
The actual income tax expense amounts for the years ended December 31, 2020 and 2019 differed from the expected tax amounts computed by applying the U.S. federal corporate income tax rate of 21% for 2020 and 2019 to the amounts of loss before income taxes as presented below (in thousands):
 
    
Year Ended

December 31,
2020
    
Year Ended

December 31,
2019
 
Pre-tax
book loss
   $ (48,990    $ (53,295
Tax at Federal statutory rate of 21% in 2020 and 2019
     (10,288      (11,192
State taxes
     879        766  
Stock based compensation
     3        1,060  
Foreign rate differential
     (1,223      (871
Unrecognized tax benefit
     549        —    
Other adjustments
     1,453        (1,707
Valuation allowance
     9,563        12,663  
    
 
 
    
 
 
 
Total income tax provision
   $ 936      $ 719  
    
 
 
    
 
 
 
                 
The domestic and foreign components of loss before income taxes from continuing operations for the years ended December 31, 2020 and 2019 are as follows (in thousands):
 
    
Year Ended

December 31,
2020
    
Year Ended

December 31,
2019
 
Domestic
   $ (46,686    $ (52,438
Foreign
     (2,304      (857
    
 
 
    
 
 
 
Total
   $ (48,990    $ (53,295
    
 
 
    
 
 
 
 
The tax effects of temporary differences at December 31, 2020 and 2019 are as follows (in thousands):
 
    
Year Ended

December 31,
2020
    
Year Ended

December 31,
2019
 
Net operating losses and other carryforwards
   $ 42,859      $ 41,299  
Interest expense carryforward
     30,112        20,070  
Property and equipment
     2,448        2,221  
Accrued expenses
     512        82  
Payroll tax deferral
     1,089        —    
Allowance for doubtful accounts
     1,768        1,517  
Stock-based compensation
     878        —    
Other
     540        633  
    
 
 
    
 
 
 
Deferred tax asset
     80,206        65,822  
Valuation allowance
     (65,228      (51,895
    
 
 
    
 
 
 
Total deferred tax assets, net of valuation allowance
     14,978        13,927  
Intangible assets
     (21,791      (20,098
Prepaid expenses
     (107      (73
Other
     (415      (50
    
 
 
    
 
 
 
Deferred tax liability
     (22,313      (20,221
    
 
 
    
 
 
 
Net deferred tax liability
   $ (7,335    $ (6,294
    
 
 
    
 
 
 
At December 31, 2020 and 2019, the Company had tax effected U.S. federal net operating loss carryforwards of approximately $32.1 million and $31.0 million, respectively, of which $7.8 million tax effected, begin to expire in 2024 but approximately $16.5 million, tax effected, begin to expire in 2035 and $7.8 million, tax effected, have no expiration. At December 31, 2020 and 2019, the Company had tax effected state net operating loss carryforwards of approximately $6.7 million and $6.5 million, respectively. The majority of the state tax losses will not begin expiring until 2035 or later. At December 31, 2020 and 2019, the Company also had U.S. tax credit carryforwards of approximately $0.9 million and $0.9 million, respectively. The tax credits will expire in 2021.
The tax effected foreign net operating loss at December 31, 2020 and 2019 is approximately $3.1 million and $2.9 million, respectively, the majority of which has an unlimited carryforward period.
The Company operates in multiple tax jurisdictions and, in the normal course of business, its tax returns are subject to examination by various taxing authorities. Such examinations may result in future assessments by these taxing authorities. The Company is subject to examination by U.S. tax authorities beginning with the year ended December 31, 2016. The Company is also subject to examination in various foreign jurisdictions. In material foreign jurisdictions, the statute of limitations ranges one
four
years from the filing of a tax return.
The Company has not provided for U.S. income and foreign withholding taxes on approximately $13.5 million of certain foreign subsidiaries’ undistributed earnings as of December 31, 2020, because such earnings have been retained and are intended to be indefinitely reinvested outside of the U.S. These earnings could become subject to additional tax, if they were remitted as dividends, loaned to the Company, or if the Company should sell its stock in these foreign subsidiaries. However, it is not practicable to estimate the amount of taxes that would be payable for these earnings because such tax, if any, is dependent on circumstances existing if and when a taxable event occurs.
Valuation Allowance
As of December 31, 2020 and 2019, the Company had a valuation allowance of $65.2 million and $51.9 million, respectively, against certain deferred tax assets. The valuation allowance relates to the deferred tax assets of the Company’s U.S. entities, including federal and state tax attributes and timing differences, as well as the deferred tax assets of certain foreign subsidiaries. The increase in the valuation allowance during 2020 is primarily related to operating losses incurred during the year and the limitation on deductibility of interest expense. To the extent the Company determines that, based on the weight of available evidence, all or a portion of its valuation allowance is no longer necessary, the Company will recognize an income tax benefit in the period such determination is made for the reversal of the valuation allowance. If management determines that, based on the weight of available evidence, it is
more-likely-than-not
that all or a portion of the net deferred tax assets will not be realized; the Company may recognize income tax expense in the period such determination is made to increase the valuation allowance. It is possible that such reduction of or addition to the Company’s valuation allowance may have a material impact on the Company’s results from operations. The U.S. federal and foreign changes to valuation allowance of approximately $9.6 million is presented in the effective tax rate reconciliation as part of the valuation allowance. The U.S. state changes to valuation allowance of approximately $3.8 million is presented as part of the state taxes in the effective tax rate reconciliation as part of the unrecognized tax benefit.
A summary of the deferred tax asset valuation allowance is as follows:
 
    
Year Ended

December 31,
2020
    
Year Ended

December 31,
2019
 
Beginning Balance
   $ 51,895      $ 36,595  
Additions
   $ 14,149      $ 15,622  
Reductions
     (816      (322
    
 
 
    
 
 
 
Ending Balance
   $ 65,228      $ 51,895  
    
 
 
    
 
 
 
Uncertain Tax Positions
As of December 31, 2020 and 2019, the total amount of unrecognized tax benefits was $1.0 million and $0 million, respectively, that would favorably impact the Company’s effective income tax rate. However, due to the Company’s determination that the deferred tax asset would not
more-likely-than-not
be realized, a full valuation allowance was recorded, therefore, zero net impact resulted in the Company’s effective income tax rate. The Company’s uncertain income tax position liability has been recorded to deferred income taxes to offset the tax attribute carryforward amounts. The U.S. federal and foreign changes to uncertain tax positions of approximately $0.6 million is presented in the effective tax rate reconciliation as part of the unrecognized tax benefit. The U.S. state changes to uncertain tax positions of approximately $0.4 million is presented as part of the state taxes in the effective tax rate reconciliation as part of the unrecognized tax benefit.
A summary of the unrecognized tax benefits is as follows:
 
    
Year Ended

December 31,
2020
 
Beginning Balance
   $ —    
Additions
   $ 1,002  
Reductions
     —    
    
 
 
 
Ending Balance
   $ 1,002